Management Team

Screenshot 2025-09-17 181138

Björn Pilström

Chief Executive Officer
Chief Medical Officer

Björn Pilström holds an MD from the Karolinska Institute and a PhD in Immunology from Stockholm University. He has more than 25 years’ global experience from the life science industry in both medical, commercial and managerial roles for larger and smaller pharmaceutical and medical device companies.

Henrik Otendal

Chief Financial Officer
Human Resource Manager

Henrik Otendal has a financial background and extensive experience in senior positions across various industries. He is active as a board member and advisor in several companies within different sectors such as the automotive industry, med tech, and shipping.

Henrik Otendal
Anita Tocaj

Anita Westin Tocaj

Head of Regulatory Affairs

Anita Tocaj holds an MSc and PhD in Biotechnology from Lund University. She has extensive expertise from CMC and regulatory work as a consultant for CRO companies and from smaller pharmaceutical companies.

Antonio Bermejo Gomez

Head of CMC

Antonio Bermejo Gómez holds an MSc and PhD in Chemistry from the University of Seville. He has extensive expertise in CMC, drug development and project management, as well as consultancy roles within the pharmaceutical sector. His background includes earlier experience in academia and drug discovery.

Antonio
??????????

Erika Egrelius

Head of Quality Assurance
Erika Egrelius is a Senior Quality Assurance specialist with a degree in chemical engineering. She has over 30 years’ experience from leading QA roles in small and medium-sized pharmaceutical companies and commercial manufacturers in the life-science industry.

Johan Olsson

Head of Accounting

Johan Olsson holds an MBA from Lund University and specializes in accounting and auditing. He has previously worked at Nyström & Partners Revision AB, BJT Consulting AB and Personal Accounting Sweden AB.

Johan Olsson
Staffan Dahlgren

Staffan Dahlgren

Head of Drug Safety

Staffan Dahlgren is a senior pharmacovigilance professional with a BSc in Pharmacy from Uppsala University and more than 25 years’ experience from life science and global drug development in several different companies. His experience includes postmarketing pharmacovigilance and clinical drug safety as well as clinical development and project management.